Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, and Clinical Research Institute, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea.
AJR Am J Roentgenol. 2010 Apr;194(4):1124-30. doi: 10.2214/AJR.09.3030.
The purpose of this study was to evaluate retrospectively the radiologic findings and imaging response of hepatocellular carcinoma supplied by the left inferior phrenic artery.
From January 2000 through December 2008, chemoembolization of the left inferior phrenic artery was performed on 152 patients (123 men, 29 women; mean age, 55.8 years) with hepatocellular carcinoma. The CT scans and digital subtraction angiograms of these patients were retrospectively reviewed in consensus by two investigators, who evaluated tumor location, tumor-feeding vessels, origin of the left inferior phrenic artery, technical success of chemoembolization, complications, and tumor response. Tumor response was assessed on the basis of the criteria of the European Association for the Study of the Liver.
Tumors supplied by the left inferior phrenic artery were located in Couinaud segment 2/3 (n = 100), segment 4 (n = 45), and other segments (n = 7). The most common tumor-feeding vessel was the anteromedial limb of the left inferior phrenic artery (n = 82) followed by the lateral limb (n = 40) and the anterior limb (n = 30). Selective chemoembolization via the left inferior phrenic artery was achieved in 58 of the patients (38%). Complete or partial response as detected on first follow-up CT images (mean follow-up time, 2.5 months) was achieved by 30 patients. In 33 patients in whom the tumor was supplied exclusively by the left inferior phrenic artery, the tumor response was more favorable in patients who underwent selective than in those who underwent nonselective chemoembolization via the left inferior phrenic artery (p = 0.028).
Selective chemoembolization via the left inferior phrenic artery is possible and results in good response of tumors supplied exclusively by the left inferior phrenic artery.
本研究旨在回顾性评估由膈下左动脉供应的肝细胞癌的影像学表现和影像反应。
自 2000 年 1 月至 2008 年 12 月,对 152 例(123 例男性,29 例女性;平均年龄 55.8 岁)肝细胞癌患者施行膈下左动脉化疗栓塞术。由两名研究者共同对这些患者的 CT 扫描和数字减影血管造影进行回顾性评估,评估内容包括肿瘤位置、肿瘤供养血管、膈下左动脉起源、化疗栓塞的技术成功率、并发症和肿瘤反应。肿瘤反应根据欧洲肝脏研究协会的标准进行评估。
膈下左动脉供应的肿瘤位于 Couinaud 段 2/3(n=100)、段 4(n=45)和其他段(n=7)。最常见的肿瘤供养血管是膈下左动脉的前内侧支(n=82),其次是外侧支(n=40)和前支(n=30)。58 例患者(38%)通过膈下左动脉实现了选择性化疗栓塞。30 例患者在首次随访 CT 图像(平均随访时间 2.5 个月)上显示完全或部分缓解。在 33 例肿瘤完全由膈下左动脉供应的患者中,选择性化疗栓塞的患者肿瘤反应优于非选择性化疗栓塞(p=0.028)。
通过膈下左动脉选择性化疗栓塞是可行的,并且对仅由膈下左动脉供应的肿瘤有良好的反应。